Notably, we observed that overexpressed HDAC1 was associated with the downregulation of OAZ1 in advanced NSCLC patients with cisplatin treatment, and predicted chemotherapy resistance and bad outcome. This evidence concerns the gene OAZ1 and non-small cell lung carcinoma.